Area of research
Cancer Research · Pathology and Forensic Medicine
Research interest
Research focused on Breast cancer and Oncology, with related work in DNA methylation, Pertuzumab, Pathogenesis. Notable publications include 'The cancer-associated microprotein CASIMO1 controls cell proliferation and interacts with squalene epoxidase modulating lipid droplet formation', 'Genome‐wide methylation screen in low‐grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis', and 'Strong EGFR signaling in cell line models of ERBB2-amplified breast cancer attenuates response towards ERBB2-targeting drugs'.
Novel chimeric antigen receptors for the effective and safe treatment of NY‐BR‐1 positive breast cancer
Magnetic resonance imaging system for intraoperative margin assessment for DCIS and invasive breast cancer using the ClearSight™ system in breast‐conserving surgery—Results from a postmarketing study
The cancer-associated microprotein CASIMO1 controls cell proliferation and interacts with squalene epoxidase modulating lipid droplet formation
Acinar cell carcinomas of the pancreas: a molecular analysis in a series of 57 cases
Breast Cancers with a <i>BRCA1</i> -like DNA Copy Number Profile Recur Less Often Than Expected after High-Dose Alkylating Chemotherapy
CT-guided Irreversible Electroporation in an Acute Porcine Liver Model: Effect of Previous Transarterial Iodized Oil Tissue Marking on Technical Parameters, 3D Computed Tomographic Rendering of the Electroporation Zone, and Histopathology
Identification of NY‐BR‐1‐specific CD4<sup>+</sup> T cell epitopes using HLA‐transgenic mice
Transarterielle Chemoembolisation (TACE) in Kombination mit irreversibler Elektroporation (IRE): Eine experimentelle Machbarkeitsstudie zur perkutanen Elektrochemotherapie in der Leber
Multigene Assays for Classification, Prognosis, and Prediction in Breast Cancer: a Critical Review on the Background and Clinical Utility
Intrinsic breast cancer subtypes defined by estrogen receptor signalling—prognostic relevance of progesterone receptor loss
Abstract 1824: The non-coding RNA landscape of lung, liver and breast cancer reveals novel tumor-associated ncRNAs, concerted regulation and unexpected tissue specificity.
Effects of mTOR Inhibition On IR/IGF-1R Signalling in PIK3CA-Mutated, Tamoxifen Resistant Breast Cancer
Genome‐wide methylation screen in low‐grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis
Strong EGFR signaling in cell line models of ERBB2-amplified breast cancer attenuates response towards ERBB2-targeting drugs
Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unit